Literature DB >> 23266467

Fear of hypoglycaemia in patients with type 1 diabetes: do patients and diabetologists feel the same way?

P Böhme1, E Bertin, E Cosson, N Chevalier.   

Abstract

AIM: This study described and compared the perception of hypoglycaemia in both patients with type 1 diabetes and diabetologists.
METHODS: This was an observational cross-sectional study undertaken in France in 2011. Data for what hypoglycaemia represents and practices related to it were collected using a questionnaire completed by patients with type 1 diabetes (all>12 years of age) and their diabetologists. Agreement between patients and physicians was evaluated by the intraclass correlation coefficient (ICC) and Gwet's coefficient (GC).
RESULTS: A total of 485 patients were enrolled by 118 diabetologists. Half the patients thought that hypoglycaemia was always symptomatic. According to both patients and diabetologists, hypoglycaemia impaired quality of life, caused anxiety and was disturbing, especially at night. Clinical symptoms of hypoglycaemia (sweating, shakiness, anxiety) were linked to patient's age and diabetes duration. Regarding hypoglycaemia frequency, agreement was good for severe hypoglycaemia (GC: 0.61 and 0.72 for diurnal and nocturnal hypoglycaemia, respectively) and poor for mild hypoglycaemia (ICC: 0.44 and 0.40, respectively). Diabetologists correctly evaluated the impact of hypoglycaemia on quality of life, but overestimated the hypoglycaemia-induced burden and anxiety. Counteractive behaviours were frequent: 23% of patients decreased their insulin dose, 20% increased their sugar intake and 12% ate extra snacks. Diabetologists were generally aware of these measures, but not of how often patients used them.
CONCLUSION: Diabetologists and patients do not share enough information about hypoglycaemia. Fear of hypoglycaemia and counteractive behaviours should be looked for by diabetologists. Systematic advice and specially adapted education should also be provided to increase patients' awareness of hypoglycaemia.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266467     DOI: 10.1016/j.diabet.2012.10.006

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  13 in total

1.  Fear of hypoglycemia: Influence on glycemic variability and self-management behavior in young adults with type 1 diabetes.

Authors:  Pamela Martyn-Nemeth; Laurie Quinn; Sue Penckofer; Chang Park; Vanessa Hofer; Larisa Burke
Journal:  J Diabetes Complications       Date:  2017-01-20       Impact factor: 2.852

Review 2.  Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes.

Authors:  A J M Verberne; W S Korim; A Sabetghadam; I J Llewellyn-Smith
Journal:  Br J Pharmacol       Date:  2016-03-08       Impact factor: 8.739

3.  Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study.

Authors:  Morey W Haymond; Maria J Redondo; Siripoom McKay; Martin J Cummins; Brett Newswanger; John Kinzell; Steven Prestrelski
Journal:  Diabetes Care       Date:  2016-02-09       Impact factor: 19.112

4.  Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia.

Authors:  Eric D Foster; Nancy D Bridges; Irene D Feurer; Thomas L Eggerman; Lawrence G Hunsicker; Rodolfo Alejandro
Journal:  Diabetes Care       Date:  2018-03-21       Impact factor: 19.112

5.  Predicting and Preventing Nocturnal Hypoglycemia in Type 1 Diabetes Using Big Data Analytics and Decision Theoretic Analysis.

Authors:  Clara Mosquera-Lopez; Robert Dodier; Nichole S Tyler; Leah M Wilson; Joseph El Youssef; Jessica R Castle; Peter G Jacobs
Journal:  Diabetes Technol Ther       Date:  2020-05-14       Impact factor: 6.118

Review 6.  Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation.

Authors:  Thomas O Mundinger; Gerald J Taborsky
Journal:  Diabetologia       Date:  2016-06-24       Impact factor: 10.122

7.  The MiaoMiao study: can do-it-yourself continuous glucose monitoring technology improve fear of hypoglycaemia in parents of children affected by type 1 diabetes?

Authors:  Mona Elbalshy; Sara Boucher; Barbara Galland; Jillian J Haszard; Hamish Crocket; Esko Wiltshire; Craig Jefferies; Martin I de Bock; Paul Tomlinson; Shirley Jones; Benjamin J Wheeler
Journal:  J Diabetes Metab Disord       Date:  2020-10-30

8.  Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves.

Authors:  Thomas O Mundinger; Qi Mei; Alan K Foulis; Corinne L Fligner; Rebecca L Hull; Gerald J Taborsky
Journal:  Diabetes       Date:  2016-05-13       Impact factor: 9.461

9.  Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.

Authors:  Halis Kaan Akturk; Janet K Snell-Bergeon; Amanda Rewers; Leslie J Klaff; Bruce W Bode; Anne L Peters; Timothy S Bailey; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2018-09-15       Impact factor: 6.118

10.  Fear of hypoglycaemia and self-management in type 1 diabetes.

Authors:  Aila J Ahola; Markku Saraheimo; Riitta Freese; Sari Mäkimattila; Carol Forsblom; Per-Henrik Groop
Journal:  J Clin Transl Endocrinol       Date:  2016-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.